Back
BioMarin Pharmaceutical Inc.
Founded by : Alexander Hardy, 1 January 1966
About the Company
BioMarin Pharmaceutical Inc. is a biotechnology company that specializes in developing and producing innovative therapies for rare genetic diseases and conditions. Founded in 1997 and headquartered in California, the company has a global presence and is committed to improving patient outcomes through groundbreaking research and development. BioMarin's portfolio includes several FDA-approved treatments for rare diseases such as phenylketonuria (PKU), hemophilia A and B, and mucopolysaccharidosis type I (MPS I), among others. With a strong focus on patient-centricity and collaboration with healthcare providers and patient advocacy groups, BioMarin continues to push the boundaries of medicine and make a significant impact in the field of rare diseases.
Industry Type
According to the GICS (Global Industry Classification Standard) version of March 2023, BioMarin Pharmaceutical Inc.’s industry classification falls within the following categories:
- Sector: Health Care
- Industry group: Pharmaceuticals, Biotechnology & Life Sciences
- Industry: Biotechnology
- Sub-Industry: Biotechnology
Videos and Photos
Company Address
770 Lindaro Street San Rafael, CA 94901 United States
Source : Google maps